“This result changes everything,” said principal investigator Professor Ed Wild, from UCL’s Huntington’s Disease Centre. “On ...

AMT-130 is the first gene therapy tested in people with Huntington’s disease. It was developed by uniQure, a company based in ...

A one-time experimental treatment shows unprecedented success in slowing Huntington's disease, according to UCL researchers.

In 2021, a few years after her father started showing symptoms, Carly Evans tested positive for the Huntington’s disease gene ...

A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported.

A new gene therapy treatment developed by uniQuire has shown promise in reducing the progression of Huntington’s Disease by ...

An experimental gene therapy slowed Huntington’s by up to 75 percent in a small clinical trial. While not a cure, it may give patients longer lives.

An experimental gene therapy has slowed the progression of Huntington’s disease by 75 percent, according to results reported ...

For the first time, scientists have successfully treated someone suffering from Huntington's disease, a fatal genetic illness with no cure.

An experimental gene therapy was found to slow the progression of Huntington’s disease in a “pivotal” study, according to drugmaker uniQure, marking a major step toward a potential first genetic ...

It is the first time a drug trial has slowed the rare disorder’s progression in an ongoing, significant way, researchers said. View on euronews ...

EAU CLAIRE, Wis. (WEAU) - A community walk bringing awareness for Huntington’s Disease is back in Eau Claire for their ninth straight year. As part of the Wisconsin Chapter of the Huntington’s Disease ...